Patent Grant
10221136
This invention relates to cooling compounds.
Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.
One class of cooling compounds that have enjoyed substantial success consists of N-substituted p-menthane carboxamides. Examples of these compounds are described in, for example, British Patents GB 1,351,761-2 and U.S. Pat. No. 4,150,052.
It has now been found that a particular selection of such compounds exhibits a cooling effect that is both surprisingly strong and long-lasting. A method is provided, therefore, of providing a cooling effect to a product, comprising the incorporation into the product of at least one compound of the formula I
in which m is a number between 0 and 2, X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that
Me is defined as methyl, and Et is defined as ethyl.
Examples of cyclic radicals as described under (b) above include 3-para-menthyl, bornyl and adamantyl.
The compounds of formula (I) may comprise one or more chiral centres and as such may exist as a mixture of stereoisomers, or they may be resolved as isomerically pure forms. Resolving stereoisomers adds to the complexity of manufacture and purification of these compounds and so it is preferred to use the compounds as mixtures of their stereoisomers simply for economic reasons. However, if it is desired to prepare individual stereoisomers, this may be achieved according to methods known in the art, e.g. preparative HPLC and GC or by stereoselective syntheses.
In some embodiments, the compounds are those in which X, Y, Z are H, OH, Me or OMe. In certain embodiments, the compounds are those in which m is 2; X, Y and Z are H or Me and R1, R2 and R3 are taken from Table 1.
A particularly effective compound is that in which R1 is H and R2 and R3 together form a 3-p-menthyl ring.
Examples of effective compounds are (1R,2S,5R)-2-isopropyl-5-methyl-N-(pyridinalkyl)cyclohexanecarboxamide and (2S,5R)-2-isopropyl-5-methyl-N-(pyridinalkyl)cyclohexanecarboxamide. Particular examples of these are (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-4-yl)ethyl)cyclohexanecarboxamide and (2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-4-yl)ethyl)cyclohexanecarboxamide.
Certain of the compounds are novel. A compound is therefore provided of the formula I as hereinabove described, in which m=2 and X, Y, Z, R1, R2, R3 have the meanings given hereinabove, with the proviso that when R2 and R3 form a para-menthyl ring, at least one of R1, X, Y and Z is a moiety other than H.
A compound is also provided according to formula I as hereinabove described, in which X, Y, Z, R1 are H and R2, R3 have the meanings given hereinabove. In certain embodiments R1 is hydrogen and R2 and R3 are independently selected from the group consisting of Me, Et and C3-C4 branched alkyl; or R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
The compounds may be easily prepared and isolated by art-recognized methods.
They are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 100 times higher than that of similar known compounds) and by the longevity of the cooling effect. These compounds also have a high solubility in oily solvents, such as mint oils, and acidic aqueous solutions, such as soft drinks. These features expand the uses of cooling compounds to a larger variety of products.
The compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation. By “applying” is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation. In the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition. There is also provided, therefore, a method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound as hereinabove described.
The range of products in which the compounds may be used is very wide, and it includes by way of example only, dentifrices such as toothpaste and toothgel, mouthwashes, foodstuffs, beverages, confectionery, tobacco products, skin creams and ointments, both cosmetic and medicinal.
The compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (Frescolat™ ML), menthone glycerine acetal (Frescolat™ MGA), mono-menthyl succinate (Physcool™), mono-menthyl glutarate, O-menthyl glycerine (CoolAct™ 10), menthyl-N,N-dimethylsuccinamate and 2-sec-butylcyclohexanone (Freskomenthe™).
Certain embodiments are now further described by means of the following non-limiting examples.
To a flask are added 4.7 g (50 mmol) of pyridin-4-ylamine, 4.04 mL of pyridine and 100 mL MtBE. To this mixture, 10 g of p-menthanecarboxyl chloride are added dropwise over 5 minutes. The reaction mixture is stirred for 24 hours. To the reaction mixture, 50 mL of water are added. The mixture is separated. The organic layer is washed with 50 mL of water and 50 mL of brine. The organic layer is dried over MgSO4. The solvent is evaporated in vacuo to afford the crude product, which is recrystallized from hexanes to afford 6.2 g of the desired product with the following spectroscopic properties:
MS: 260 ([M+·]), 217, 149, 121, 95
1H NMR (300 MHz; CDCl3) δ: 8.49 (d, 2H), 7.77 (s, 1H), 7.52 (d, 2H), 2.22 (td, 1H), 1.9 (broad d, 2H), 1.85-1.57 (m, 3H), 1.44-1.22 (m, 2H), 1.16-0.99 (m, 2H), 0.94 (d, 3H), 0.91 (d, 3H), 0.81 (d, 3H)
13C NMR (75 MHz; CDCl3) δ: 175.4, 150.5, 145.0, 113.4, 50.7, 44.3, 39.25, 34.3, 32.1, 28.7, 23.7, 22.1, 21.2, 16.1
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 288 ([M+·]), 273, 245, 149, 121, 95
1H NMR (300 MHz; DMSO) δ: 8.53 (d, 1H), 7.62 (td, 1H), 7.16 (m, 2H), 6.43 (s, 1H), 3.67 (nontuplet, 2H), 3.00 (t, 2H), 1.95 (td, 1H), 1.84-1.53 (m, 4H), 1.47 (broad t, 1H), 1.4-1.1 (m, 2H), 0.87 (d, 3H), 0.84 (d, 3H), 0.66 (d, 3H)
13C NMR (75 MHz; DMSO) δ: 175.8, 159.7, 148.9, 136.7, 123.6, 121.55, 49.8, 44.3, 39.4, 38.35, 36.9, 34.6, 32.3, 28.55, 23.9, 22.3, 21.3, 15.95
A preparation similar to that described in example 1, using 2-isopropyl-2,3-dimethylbutanoyl chloride, gives the desired product with the following spectroscopic properties:
MS: 262 ([M+]), 220, 205, 149, 121, 106, 93
1H NMR (300 MHz; CDCl3) 8.53 (d, 1H), 7.63 (t, 1H), 7.16 (m, 2H), 6.69 (s, 1H), 3.67 (dd, 2H), 2.99 (t, 2H), 1.96 (m, 2H), 0.96 (s, 3H), 0.85 (d, 6H), 0.79 (d, 6H)
13C (75 MHz; CDCL3) 175.6, 160.0, 149.1, 136.6, 123.4, 121.5, 51.4, 38.4, 36.9, 32.6, 18.1, 17.4, 14.1
A small group of panelists is asked to taste various aqueous solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2 ppm. The same panel is asked to taste these solutions at the chosen concentrations and to record the cooling intensity at regular time intervals until no cooling could be sensed in the mouth. The results are shown in Table 2.
From Table 2, it can be seen that the compounds of Formula I are up to 100 times stronger and last longer than menthol, the reference cooling compound. Compounds of Formula I are also much stronger than WS-3, the best cooling compound of the prior art.
In a second experiment, the same panel is asked to taste various solutions of compounds having various concentrations and to indicate which of these solutions had a cooling intensity similar to or slightly higher than that of a solution of menthol at 2 ppm. This is the “isointensive concentration”. The results are shown in Table 3.
From Table 2 and 3, it can be seen that compounds of Formula I with various chain lengths and substitution patterns all have lower usage levels than the reference cooling chemicals, menthol and WS-3.
All the ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An icy-cool sensation is felt in every area of the mouth as well as lips.
The chemicals are mixed in the toothgel, a piece of toothgel is put on a toothbrush and a panelist's teeth are brushed. The mouth is rinsed with water and the water is spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth.
1.5 mg of the compound of example 2 is dissolved in a 355 mL (12 fl oz.) can of clear lemon/lime soda. A panelist experiences an agreeable delayed cooling sensation in the mouth with no throat burning. No unpleasant after-taste is observed.
Although the invention has been described in detail through the above detailed description and the preceding examples, these examples are for the purpose of illustration only and it is understood that variations and modifications can be made by one skilled in the art without departing from the spirit and the scope of the invention. It should be understood that the embodiments described above are not only in the alternative, but can be combined.
The present application is a continuation of co-pending U.S. Ser. No. 11/990,103, having a 371(c) date of Sep. 16, 2009, which is a 371 of PCT/CH2006/000427, filed Aug. 14, 2006, which claims the benefit of the filing date under 35 USC § 119(e) of U.S. Provisional Patent Application No. 60/708,153, filed on Aug. 15, 2005, which applications are incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3516943 | Brynko et al. | Jun 1970 | A |
| 4136163 | Watson et al. | Jan 1979 | A |
| 4150052 | Watson et al. | Apr 1979 | A |
| 4190643 | Watson et al. | Feb 1980 | A |
| 4285984 | Huber | Aug 1981 | A |
| 4797411 | Crugnola | Jan 1989 | A |
| 5759599 | Wampler et al. | Jun 1998 | A |
| 5843466 | Mane | Dec 1998 | A |
| 6039901 | Soper et al. | Mar 2000 | A |
| 6045835 | Soper et al. | Apr 2000 | A |
| 6056949 | Menzi et al. | May 2000 | A |
| 6106875 | Soper et al. | Aug 2000 | A |
| 6123974 | Gautschi et al. | Sep 2000 | A |
| 6222062 | Anderson et al. | Apr 2001 | B1 |
| 6306818 | Anderson et al. | Oct 2001 | B1 |
| 6325859 | De Roos et al. | Dec 2001 | B1 |
| 6325951 | Soper et al. | Dec 2001 | B1 |
| 6335047 | Daniher et al. | Jan 2002 | B1 |
| 6348618 | Anderson et al. | Feb 2002 | B1 |
| 6348625 | Anderson et al. | Feb 2002 | B1 |
| 6387431 | Gautschi | May 2002 | B1 |
| 6426108 | Gautschi | Jul 2002 | B1 |
| 6436461 | Bouwmeesters et al. | Aug 2002 | B1 |
| 6440912 | McGee et al. | Aug 2002 | B2 |
| 6451366 | Daniher et al. | Sep 2002 | B1 |
| 6482433 | De Roos et al. | Nov 2002 | B1 |
| 6610346 | Acuna et al. | Aug 2003 | B1 |
| 6689740 | McGee et al. | Feb 2004 | B1 |
| 6805893 | Acuna et al. | Oct 2004 | B2 |
| 6869923 | Cunningham et al. | Mar 2005 | B1 |
| 20010008635 | Quellet et al. | Jul 2001 | A1 |
| 20020081370 | Daniher et al. | Jun 2002 | A1 |
| 20030082272 | Bouwmeesters et al. | May 2003 | A1 |
| 20030165587 | Binggeli et al. | Sep 2003 | A1 |
| 20040047960 | Acuna et al. | Mar 2004 | A1 |
| 20050054651 | Natarajan et al. | Mar 2005 | A1 |
| 20050187211 | Wei | Aug 2005 | A1 |
| 20050214337 | McGee et al. | Sep 2005 | A1 |
| 20050227906 | Schudel et al. | Oct 2005 | A1 |
| 20050233042 | Galopin et al. | Oct 2005 | A1 |
| 20060035008 | Virgallito et al. | Feb 2006 | A1 |
| 20060051301 | Galopin et al. | Mar 2006 | A1 |
| 20060154850 | Quellet et al. | Jul 2006 | A1 |
| 20060172917 | Vedantam et al. | Aug 2006 | A1 |
| 20060276667 | Galopin et al. | Dec 2006 | A1 |
| 20080319055 | Cole et al. | Dec 2008 | A1 |
| Number | Date | Country |
|---|---|---|
| 7593174 | Mar 1976 | AU |
| 491 111 | May 1970 | CH |
| 24 58 562 | Jun 1975 | DE |
| 1 351 761 | May 1974 | GB |
| WO 9323005 | Nov 1993 | WO |
| WO 2001003825 | Jan 2001 | WO |
| WO 2004034791 | Apr 2004 | WO |
| WO 2005002582 | Jan 2005 | WO |
| WO 2005020897 | Mar 2005 | WO |
| WO 2006056087 | Jun 2006 | WO |
| WO 2006056096 | Jun 2006 | WO |
| WO 2006092076 | Sep 2006 | WO |
| Entry |
|---|
| PCT/CH2006/000427—International Search Report, dated Nov. 16, 2006. |
| PCT/CH2006/000427—International Written Opinion, dated Nov. 16, 2006. |
| PCT/CH2006/000427—International Preliminary Report on Patentability, dated Feb. 20, 2008. |
| Number | Date | Country | |
|---|---|---|---|
| 20170008845 A1 | Jan 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60708153 | Aug 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11990103 | US | |
| Child | 15276248 | US |
